A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management

Abstract

Glaucoma is a leading cause of preventable blindness globally. Nearly, half of the patients who have glaucoma in the United States are unaware of their diagnosis, and this number is far greater in resource poor areas. The risk of progressive and irreversible loss of vision is decreased with an early diagnosis, and better access to treatment is vital to improve the visual outcome for patients. We therefore postulated that a minimally invasive, low-cost calculator used to predict the risk of glaucoma and inform the course of follow-up care will improve patient prognosis. We retrospectively examined data from 104 eyes of patients who underwent a complete ocular examination, visual field, and corneal pachymetry at Advanced Eye Care of New York (54 with glaucoma and 50 controls). Receiver operating curves (ROC) were utilized to determine the correct glaucoma classification rates of the Laroche glaucoma calculator (Range −3 to 18), a novel tool that combines age, intraocular pressure (IOP), and central corneal thickness (CCT) into a composite metric. Additionally, we compared the discriminatory power of this calculator to age, intraocular pressure (IOP), and central corneal thickness (CCT) separately. A score of greater than or equal to 6 on the Laroche glaucoma calculator (sensitivity 90.74%, specificity 64.00%, correct classification 77.88%) optimizes the accuracy of this tool. Compared to IOP (Area Under the Curve (AUC) = 0.72, chi2 = 4.21, p = 0.04 ) and CCT (AUC = 0.53), chi2 24.72 p < 0.001 ), the Laroche glaucoma calculator (AUC = 0.81) was significantly better at discriminating against glaucoma patients vs. controls. These results demonstrate that the Laroche calculator is a novel, effective tool for identifying glaucoma, and it may provide a low-cost risk stratification tool, particularly in areas with limited resources.

The Achievement of IOP Target Among a Sample of Iraqi Patients with Glaucoma: A Retrospective Study

“… 16 However, a low-cost screening technique is available now for early detection of such cases and cataract surgery could help in this regard, with or without microinvasive glaucoma surgery and thus no medication may be needed. 17 …”

The Importance of Gonioscopy and Angle Assessment in Ocular Hypertension

“…Close observation and assessment of ocular hypertension are essential for promptly identifying the etiology and potential interventions to prevent vision impairments. The Laroche glaucoma calculator helps to identify patients who may be at increased risk based not only on IOP but also age and central corneal thickness [4]. Thus, the clinical management of ocular hypertension upholds the beliefs of preventative medicine and involves regular monitoring and risk stratification to ascertain patients with an elevated risk of developing glaucoma [39].…”

“…Ocular hypertension is a condition that is specified by an increase in intraocular pressure without any visible optic nerve damage or visual field loss [1][2][3][4][5]. The prevalence of ocular hypertension is approximately 2.7-3.8% in the general population and the incidence increases with the onset of age [6].…”